Related Experiment Video
Updated: Aug 7, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
L-nucleoside enantiomers as antivirals drugs: a mini-review
Christophe Mathé1, Gilles Gosselin
1Laboratoire de Chimie Organique Biomoléculaire de Synthèse, UMR 5625 CNRS, Université Montpellier II, Case Courrier 008, Place Eugène Bataillon, 34095 Montpellier, France.
Abstract:
The discovery that some nucleoside analogues endowed with the unnatural L-configuration can possess biological activities has been a significant breakthrough in antiviral chemotherapy. In this regard, lamivudine (3TC) was the first L-nucleoside enantiomer approved against HIV and HBV, and several other L-nucleosides are currently under clinical development as antiviral agents.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
DNA Base Pairing
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Subviral Agents

